From June 20 to 21, the 2025 Annual Academic Conference of the Urology and Andrology Branch of the Hebei Medical Association—hosted by the Hebei Medical Association and co-organized by the 980th Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army and the Second Hospital of Hebei Medical University—was grandly held in Shijiazhuang.
This prominent event aimed to foster the exchange and promotion of the latest advancements in diagnosis, technology, surgical techniques, and treatment experience within the fields of urology and andrology. As a company dedicated to innovative medical devices in these domains, Shenzhen Surgsci Medical Technology Co., Ltd. was honored to be invited as an exhibitor. The company showcased and promoted cutting-edge theories, technologies, and achievements from both China and abroad to experts and peers attending the event.
▍ Conference Highlights
The conference brought together many of the country’s leading experts in urology and andrology, who shared groundbreaking research findings and invaluable clinical experience. A series of high-level academic lectures and case discussions offered attendees a rich and rewarding academic experience.
▍ Surgsci Booth Showcase
At the exhibition, Surgsci presented its latest innovations in urology, including the Surgsci Chasing Light™ Ultrasonic Scalpel, single-use laparoscopic trocars, and several ureteral stent systems. These core products drew the attention of numerous experts who stopped by the booth to engage in in-depth discussions about product performance and application potential.
▍ Key Product Highlights
Urology and andrology are evolving rapidly—from the widespread application of minimally invasive techniques to the deepening exploration of precision medicine, from advances in prostate disease treatment to breakthroughs in male reproductive health research. Each innovation reflects the collective wisdom of the industry and brings renewed hope to patients. Surgsci remains committed to empowering physicians and benefiting patients, continually striving to improve health and quality of life.
▍ About Surgsci
Surgsci focuses on core technologies and innovative applications in minimally invasive surgery, having established three major technology platforms: medical metal materials, polymer materials, and artificial intelligence algorithms. The company has developed two major product lines—surgical instruments and surgical consumables. Surgsci has successfully tackled key technical challenges in high-performance medical titanium alloys, advanced piezoelectric ceramic materials, and AI-based ultrasonic generator algorithms, resulting in the launch of intelligent ultrasonic surgical systems and several implantable and interventional surgical consumables.
Currently, the company leads key R&D programs funded by China’s Ministry of Science and Technology and major technology initiatives supported by the city of Shenzhen. It has published two high-level international academic papers and filed over 140 domestic and international patents. Driven by its vision to improve human health and quality of life, Surgsci remains grounded in clinical needs, committed to empowering healthcare professionals, and strives to contribute positively to the national healthcare sector.
